Lantheus Holdings Inc. - notizie pubblicate 285 - letture 4.988


Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Lantheus Reports First Quarter 2023 Financial Results - Form 8-K

Lantheus reports first quarter 2023 financial results •worldwide revenue of $300.8 million for the first quarter 2023, representing an increase of 44.0% from the prior year perio ...

04.05.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Lantheus Reports First Quarter 2023 Financial Results

Lantheus reports first quarter 2023 financial results may 4, 2023 worldwide revenue of $300.8 million for the first quarter 2023, representing an increase of 44.0% from the prior y ...

04.05.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Selected Historical Financial Results

The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer lantheus holdings in ...

04.05.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

1Q 2023 Reconciliation of GAAP to Non-GAAP Financial Measures

Lantheus holdings, inc. reconciliation of gaap to non-gaap financial measures (in thousands, except per share data - unaudited) three months ended march 31, 2023 march 31, 2022 gaa ...

04.05.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

1Q 2023 Reconciliation of GAAP to Non-GAAP Financial Measures

Lantheus holdings, inc. reconciliation of gaap to non-gaap financial measures (in thousands, except per share data - unaudited) three months ended march 31, 2023 march 31, 2022 gaa ...

04.05.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Management Change - Form 8-K

8-k united states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of r ...

01.05.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Lantheus and point biopharma announce fda grants fast track designation for ¹⁷⁷lu-pnt2002 for the treatment of metastatic castration resistant prostate cancer april 24, 2023 b ...

24.04.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8:00 a.m. Eastern Time

Lantheus to host first quarter 2023 earnings conference call and webcast on may 4, 2023, at 8:00 a.m. eastern time april 20, 2023 bedford, mass., april 20, 2023 (globe newswire) -- ...

20.04.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

19.04.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

19.04.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

19.04.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

19.04.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

05.04.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Amendment to Statement of Changes in Beneficial Ownership - Form 4/A

Form 4/a check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washin ...

30.03.2023
Lantheus Holdings Inc.

LANTHEUS HOLDINGS INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

29.03.2023
Condividi